POST OUTLINE 1) Introduction / Overview 2) What is the 340B Drug Pricing Program? 3) A brief history of 340B ESP The reporting burdens 340B ESP place on covered entities. The real reason behind 340B ESP? 4) How we help eligible entities deal with 340B ESP Reporting your eligible prescriptions to 340B ESP. Tracking your … Read More
Covered Entities
Best Practices Every 340B Hospital Needs To Know
If your hospital is 340B-eligible, you may be missing-out on millions of dollars in prescription reimbursements. Savings and revenue which, for some hospitals served by ProxsysRx, actually make the difference between solvency and closure. Any list of Best Practices for running a 340B program starts with maintaining compliance. Tips for maintaining 340B Program Compliance The … Read More
What is 340B Double-Dipping, and How Can You Avoid It?
The 340B drug pricing program allows eligible providers to replenish prescriptions to eligible patients at significantly reduced pricing, and bill normal market rates for those prescriptions —helping the entities fill revenue gaps that are inherent to their business models. That said, the program does not allow eligible providers to take advantage of 340B discounts and … Read More
How, and Why, TPAs Misqualify 340B-Eligible Prescriptions
PLEASE NOTE: This article should not be construed as an attack on TPAs. VytlOne has managed 340B programs for dozens of hospitals, and we can’t imagine managing one without the services of a TPA. Is your health system 340B-eligible? We still frequently get this question, so: To qualify for 340B program eligibility, you need to … Read More
How Can I Benefit My 340B Program With A Specialty Pharmacy?
Getting started with the 340b program If your hospital isn’t already 340B registered and eligible, you might want to refer to our previous blog post, Are you ready to enroll in the 340B program? What is a Specialty Pharmacy? The National Association of Specialty Pharmacy defines a specialty pharmacy as a state-licensed pharmacy that solely … Read More
How Meds To Beds Can Drive Your 340B Hospital’s Savings
NOTE: This blog post was updated at the bottom on November 24, 2025 with an introductory overview of VytlOne’s readmission reduction program — Impact®. Benefits of a Meds To Beds Program: Overview On a purely practical level, a well-managed bedside prescription delivery program can improve health system revenue. On the human level, Meds To Beds … Read More
340B-program patient eligibility: Who qualifies for 340B?
Getting started with the 340B program If your hospital isn’t already 340B registered and eligible, you might want to refer to our previous blog post, Are you ready to enroll in the 340B program? Patient eligibility: Who qualifies for the 340B program? In order to receive 340B eligible prescriptions, a patient must have already received … Read More
Are You Ready To Enroll In The 340B Drug Program?
(NOTE: The purpose of this article is to explore 340B program requirements and the process of enrolling. If you’re not already familiar with the program’s benefits, and how it can work for your Health System, Click Here.) What are the 340B-Eligible Entities? The first step in preparing your health system for enrollment in the 340B … Read More
What drugs are not eligible for 340B Savings?
POST OUTLINE 1) 340B Program Introduction / Overview Primary reasons eligible health systems don’t participate. 340B savings achieved by hospitals VytlOne supports. 2) General drug criteria for 340B eligibility The covered entity has a relationship with the patient and maintains records of care. The services are provided by a healthcare professional who is either employed … Read More
Understanding The 340B Program Requirements
POST OUTLINE 1) What Is The 340B Drug Pricing Program? How does the 340B program work? How much revenue can my hospital generate from the 340B program? 2) Who qualifies for the 340B program? What is a 340B Covered Entity? Facilities included in the 340B program 3) Understanding the 340B program requirements for eligibility Government-owned … Read More










